Media coverage
1Media coverage
Title FDA Approves Stiolto Respimat Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction Media name/outlet Pharmacy Choice Country United States Date 10/11/18 Persons Antonio R Anzueto
FDA Approves Stiolto Respimat Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction
Press/Media: Press / Media